Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U1 small nuclear 15, pseudogene (RNU1-15P) is a genomic locus in humans annotated as a pseudogene of the U1 small nuclear RNA family. While the canonical U1 snRNA forms a core component of the U1 snRNP particle that mediates recognition of the 5’-splice site during nuclear pre-mRNA splicing[3], pseudogene members such as RNU1-15P lack evidence for transcriptional or functional activity and generally do not participate in splicing or gene regulation. Such pseudogenes are considered evolutionary remnants of gene duplication events and may serve as markers for genomic studies but do not encode proteins or have direct biological, therapeutic, or disease relevance[1][4]. If the intention was to refer to the functional snRNA target involved in splicing (U1 snRNA/RNU1-1), that is a biologically essential non-coding RNA involved in splice site recognition and pre-mRNA processing[2][3]. However, RNU1-15P specifically refers to a pseudogene of this family and should not be confused with active snRNA loci.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U1 small nuclear 15, pseudogene (RNU1-15P).